In the Jak-knockout B16 melanoma model, BO-112 appears to upregulate MHC class I (especially HLA-A) in a manner that is dependent on nuclear factor kappa B (NF-κB) and independent of NLRC5 [6]. Here, NLRC5 is linked to melanoma.